IPCA-Zopiclone

Nazione: Nuova Zelanda

Lingua: inglese

Fonte: Medsafe (Medicines Safety Authority)

Principio attivo:

Zopiclone 7.5mg;  

Commercializzato da:

Ipca Pharma (NZ) Pty Limited

INN (Nome Internazionale):

Zopiclone 7.5 mg

Dosaggio:

7.5 mg

Forma farmaceutica:

Film coated tablet

Composizione:

Active: Zopiclone 7.5mg   Excipient: Calcium hydrogen phosphate dihydrate Colloidal silicon dioxide Hypromellose Lactose monohydrate Macrogol 6000 Magnesium stearate Maize starch Povidone Purified talc Sodium starch glycolate Titanium dioxide

Tipo di ricetta:

Class C5 Controlled Drug

Prodotto da:

Centaur Pharmaceuticals Private Limited

Indicazioni terapeutiche:

Treatment of transient, short-term and chronic insomnia in adults including difficulties with falling asleep, nocturnal awakening and wakening.

Dettagli prodotto:

Package - Contents - Shelf Life: Blister pack, PVC/Al in outer cardboard carton - 28 tablets - 36 months from date of manufacture stored at or below 25°C protect from light

Data dell'autorizzazione:

2013-06-14